Membrane Yeast Two-Hybrid (MYTH): A Complete Workflow for Validating Membrane Protein Interactions-Yeast Display Technology Special Topic-Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

Membrane Yeast Two-Hybrid (MYTH): A Complete Workflow for Validating Membrane Protein Interactions

Various modifications of the conventional yeast two-hybrid system have played an important role in detecting and validating protein–protein interactions between nuclear and cytosolic proteins. These approaches have not only helped uncover new interaction partners but also provided clues to their functions. However, because membrane proteins — such as receptor tyrosine kinases, G protein-coupled receptors, membrane-bound phosphatases and transporters — are hydrophobic, their interactions are difficult to study with conventional protein-interaction assays.

A yeast two-hybrid assay based on the split-ubiquitin system (that is, the membrane yeast two-hybrid, or MYTH, assay) solves this problem. The method fuses the two halves of ubiquitin to two interacting proteins, at least one of which is a membrane protein. When the two proteins interact, the two ubiquitin halves reassemble, and the transcription factor fused to the target membrane protein is cleaved and released. The liberated transcription factor then enters the nucleus and activates transcription of the reporter genes.

Figure 1. Schematic of the membrane yeast two-hybrid principle.

Why Nuclear Two-Hybrid Systems Cannot Handle Membrane Proteins

In the yeast two-hybrid system, the bait protein is fused to a DNA-binding domain (BD) and the prey protein to a transcriptional activation domain (AD). The two must meet inside the nucleus to assemble a functional transcription factor that activates the reporter genes — in other words, every step of the readout has to take place in the nucleus. To evaluate a membrane protein interaction by yeast two-hybrid, the membrane protein must therefore be truncated into fragments and re-localized to the nucleus. Yet some membrane proteins cannot be expressed efficiently in the nuclear environment, and their hydrophobicity makes biochemical analysis difficult, which complicates protein isolation and further increases the difficulty of assaying membrane protein interactions. As a result, although membrane-associated proteins make up roughly one-third of the total protein content of an organism, research on membrane proteins and on their interactions remains limited.

This is not a problem that can be solved by optimizing experimental conditions; it is an incompatibility at the level of the assay principle. Membrane protein interactions require a detection logic that does not demand nuclear entry at all.

The Split-Ubiquitin Principle and Vector Architecture

How is the split-ubiquitin system used in practice? Ubiquitin is a small protein of 76 amino acids that is cleaved after being recognized by ubiquitin-specific proteases (UBPs). Ubiquitin is split into two halves: the C-terminal half (Cub) is fused to the cytosolic side of the bait membrane protein and followed by a transcription factor, while the N-terminal half (NubG) is fused to the prey protein. NubG carries a key mutation (I13G) that prevents it from reassociating spontaneously with Cub. When bait and prey interact, Cub and NubG are brought into close proximity and refold into an intact ubiquitin moiety. Cytosolic UBPs recognize the reconstituted ubiquitin and cleave at the C-terminus of Cub, releasing LexA-VP16. The free transcription factor enters the nucleus and activates the reporter genes. Throughout the entire process, the bait protein stays anchored to the membrane and the prey never needs to enter the nucleus.

Vector architecture. In the bait vector, the protein of interest is inserted between the Ost4p membrane anchor and Cub-LexA-VP16; Ost4p tethers the whole fusion to the endoplasmic reticulum membrane and ensures correct topology. The prey vector expresses an NubG fusion protein and is used either to construct cDNA libraries or for single-gene validation. In the reporter strain NMY51, HIS3, ADE2 and lacZ under LexA control are integrated into the genome, and this triple selection keeps false positives in check. The complete MYTH principle and workflow described by Snider et al. in Nature Protocols shows that, from bait construction and validation through to library screening, the whole cycle typically takes four to six weeks.

Figure 2. Typical workflow for screening a prey cDNA library against a target bait protein by membrane yeast two-hybrid.

Bait Autoactivation Testing and Toxicity Assessment

Autoactivation testing. In MYTH, if the conformation of the bait–Cub-LexA-VP16 fusion permits non-specific cleavage by UBPs, or if the LexA-VP16 moiety is released unexpectedly, clones will grow even in the absence of prey. The standard procedure is as follows: transform the bait plasmid alone into NMY51, plate on SD-Leu, pick single colonies and measure the OD, then spot the cells onto SD-Leu-His plates with or without 3-AT. If the bait alone grows on histidine-deficient plates, autoactivation is present, and the 3-AT concentration should be raised or a vector with a weaker promoter used instead.

Toxicity assessment. Overexpression of membrane proteins — especially multi-pass transmembrane proteins — can overwhelm the yeast secretory system. After bait transformation, compare its growth curve with that of the empty-vector control in SD-Leu liquid medium. If the bait group shows a markedly delayed log phase or a final OD more than 50% lower than the control, the positive rate of the subsequent library screen will drop substantially; lowering the culture temperature to 25 °C or switching to a low-copy vector is recommended.

Comparison with Co-IP: When to Use Which

Key differences in membrane protein interaction validation methods:

1. Membrane yeast two-hybrid (MYTH). Its core strength is the discovery of unknown interactions. It does not require prior knowledge of the interacting partner and allows unbiased screening of a cDNA library.

2. Co-immunoprecipitation (Co-IP). The benchmark for endogenous interactions. Its logic is to ask whether two proteins interact in a real cell at near-physiological expression levels. However, Co-IP requires good antibodies (IP-grade), and lysis conditions must be mild enough to preserve the interaction without stripping membrane proteins off the membrane; it also cannot distinguish direct interactions from bridged ones.

The most classic use of MYTH is to take the candidate interactors identified by membrane yeast two-hybrid screening and hand them to Co-IP for confirmation.

Summary

Membrane yeast two-hybrid solves the fundamental problem that nuclear two-hybrid systems cannot address membrane protein interactions. To confirm an interaction between two membrane-associated proteins more convincingly, several detection methods should be combined: split-ubiquitin screening is used to isolate candidate interacting protein sequences, and Co-IP is then used to confirm them in a system closer to physiological conditions. Together, the two approaches make the validation far more persuasive.

About Taike Biotechnology

Taike Biotechnology (Tianjin) Co., Ltd. has, over nearly a decade, accumulated extensive experience in yeast library construction. On this basis we provide high-quality yeast hybrid services to customers worldwide. Covering yeast library construction, screening and pairwise (point-to-point) validation, our portfolio includes yeast cDNA library construction, yeast one-hybrid services and yeast two-hybrid services for both membrane and nuclear systems, giving strong technical support to our clients' research programmes.

References

1. Iyer K, Bürkle L, Auerbach D, et al. Utilizing the split-ubiquitin membrane yeast two-hybrid system to identify protein-protein interactions of integral membrane proteins. Science's STKE, 2005, 2005(275): pl3.

2. Snider J, Kittanakom S, Damjanovic D, et al. Detecting interactions with membrane proteins using a membrane two-hybrid assay in yeast. Nature Protocols, 2010, 5(7): 1281–1293.

3. Fetchko M, Stagljar I. Application of the split-ubiquitin membrane yeast two-hybrid system to investigate membrane protein interactions. Methods, 2004, 32(4): 349–362.

Previous:After the Halo Fades: How Antibody Discovery Is Returning to Science — and to Systems Next:None!